Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia

Nature Chemical Biology

Volumn 2, Issue 10, 2006, Pages 551-558

  Herman, David ^a   Jenssen, Kai ^a   Burnett, Ryan ^a   Soragni, Elisabetta ^a   Perlman, Susan L ^b   Gottesfeld, Joel M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN; HISTONE; HISTONE DEACETYLASE INHIBITOR; LYSINE;

ACETYLATION; ALLELE; ARTICLE; CELL LINE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FRIEDREICH ATAXIA; FXN GENE; GENE; GENE SILENCING; HETEROCHROMATIN; HUMAN; HUMAN CELL; LYMPHOCYTE; METHYLATION; PRIORITY JOURNAL; SYNTHESIS; TRANSCRIPTION REGULATION;

ATAXIA;

EID: 33748778745     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio815     Document Type: Article

References (43)

1. Campuzano, V. et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427 (1996).
2. Pandolfo, M. Friedreich ataxia. Semin. Pediatr. Neurol. 10, 163-172 (2003).
3. Bidichandani, S.I., Ashizawa, T. & Patel, P.I. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am. J. Hum. Genet. 62, 111-121 (1998).
4. Sakamoto, N. et al. Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia. Mol. Cell 3, 465-475 (1999).
5. Ohshima, K., Montermini, L., Wells, R.D. & Pandolfo, M. Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J. Biol. Chem. 273, 14588-14595 (1998).
6. Grabczyk, E. & Usdin, K. The GAA-TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucleic Acids Res. 28, 2815-2822 (2000).
7. Saveliev, A., Everett, C., Sharpe, T., Webster, Z. & Festenstein, R. DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature 422, 909-913 (2003).
8. Elgin, S.C. & Grewal, S.I. Heterochromatin: silence is golden. Curr. Biol. 13, R895-R898 (2003).
9. Grabczyk, E. & Usdin, K. Alleviating transcript insufficiency caused by Friedreich's ataxia triplet repeats. Nucleic Acids Res. 28, 4930-4937 (2000).
10. Napierala, M., Dere, R., Vetcher, A. & Wells, R.D. Structure-dependent recombination hot spot activity of GAA.TTC sequences from intron 1 of the Friedreich's ataxia gene. J. Biol. Chem. 279, 6444-6454 (2004).
11. Drummond, D.C. et al. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 45, 495-528 (2005).
12. Di Prospero, N.A. & Fischbeck, K.H. Therapeutics development for triplet repeat expansion diseases. Nat. Rev. Genet. 6, 756-765 (2005).
13. Langley, B., Gensert, J.M., Beal, M.F. & Ratan, R.R. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr. Drug Targets CNS Neurol. Disord. 4, 41-50 (2005).
14. Peart, M.J. et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc. Natl. Acad. Sci. USA 102, 3697-3702 (2005).
15. Sarsero, J.P. et al. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia. J. Gene Med. 5, 72-81 (2003).
16. Burnett, R. et al. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA-TTC repeats in Friedreich's ataxia. Proc. Natl. Acad. Sci. USA 103, 11497-11502 (2006).
17. Wong, J.C., Hong, R. & Schreiber, S.L. Structural biasing elements for in-cell histone deacetylase paralog selectivity. J. Am. Chem. Soc. 125, 5586-5587 (2003).
18. Dorer, D.R. & Henikoff, S. Expansions of transgene repeats cause heterochromatin formation and gene silencing in Drosophila. Cell 77, 993-1002 (1994).
19. Pohler, J.R. & Lilley, D.M. The interaction of HMG-box proteins with the four-way DNA junction. Biochem. Soc. Trans. 25, S647 (1997).
20. Zhao, Y. et al. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol. Cell. Biol. 26, 2782-2790 (2006).
21. Solomon, J.M. et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol. Cell. Biol. 26, 28-38 (2006).
22. Annunziato, A.T., Frado, L.L., Seale, R.L. & Woodcock, C.L. Treatment with sodium butyrate inhibits the complete condensation of interphase chromatin. Chromosoma 96, 132-138 (1988).
23. Tse, C., Sera, T., Wolffe, A.P. & Hansen, J.C. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell. Biol. 18, 4629-4638 (1998).
24. Annunziato, A.T. & Hansen, J.C. Role of histone acetylation in the assembly and modulation of chromatin structures. Gene Expr. 9, 37-61 (2000).
25. Shogren-Knaak, M. et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311, 844-847 (2006).
26. Strahl, B.D. & Allis, C.D. The language of covalent histone modifications. Nature 403, 41-45 (2000).
27. Stewart, M.D., Li, J. & Wong, J. Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol. Cell. Biol. 25, 2525-2538 (2005).
28. Litt, M.D., Simpson, M., Gaszner, M., Allis, C.D. & Felsenfeld, G. Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus. Science 293, 2453-2455 (2001).
29. Gui, C.Y., Ngo, L., Xu, W.S., Richon, V.M. & Marks, P.A. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. USA 101, 1241-1246 (2004).
30. Sumner, C.J. et al. Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann. Neurol. 54, 647-654 (2003).
31. Senawong, T. et al. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J. Biol. Chem. 278, 43041-43050 (2003).
32. Shestakova, E., Bandu, M.T., Doly, J. & Bonnefoy, E. Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity. J. Virol. 75, 3444-3452 (2001).
33. Suka, N., Suka, Y., Carmen, A.A., Wu, J. & Grunstein, M. Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol. Cell 8, 473-479 (2001).
34. Agalioti, T., Chen, G. & Thanos, D. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111, 381-392 (2002).
35. Astrand, C., Klenka, T., Wrange, O. & Belikov, S. Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure. Eur. J. Biochem. 271, 1153-1162 (2004).
36. Aron, J.L. et al. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood 102, 652-658 (2003).
37. Hart, P.E. et al. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch. Neurol. 62, 621-626 (2005).
38. Ghazizadeh, M. Cisplatin may induce frataxin expression. J. Nippon Med. Sch. 70, 367-371 (2003).
39. Turano, M. et al. 3-Nitropropionic acid increases frataxin expression in human lymphoblasts and in transgenic rat PC12 cells. Neurosci. Lett. 350, 184-186 (2003).
40. Sturm, B. et al. Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur. J. Clin. Invest. 35, 711-717 (2005).
41. Chuma, M. et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37, 198-207 (2003).
42. Pattyn, F., Speleman, F., De Paepe, A. & Vandesompele, J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res. 31, 122-123 (2003).
43. Luo, R.X., Postigo, A.A. & Dean, D.C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473 (1998).